# Medical cannabis for Multiple Sclerosis in the UK

Source: https://medcannaindex.com/conditions/multiple-sclerosis

For spasticity caused by multiple sclerosis that other medicines have not controlled, the licensed spray Sativex can be prescribed by a neurologist. NHS funding is available but depends on a clear response in a 4-week trial, and availability varies across the UK. Other patients are assessed privately. Whether it is suitable for you is the specialist's decision.

Multiple sclerosis (MS) is an autoimmune condition affecting the brain and spinal cord. Muscle spasticity — stiffness and involuntary muscle spasms — is one of the most disabling symptoms. Sativex (nabiximols), an oromucosal spray containing THC and CBD, is the only licensed cannabis-based medicine for MS spasticity in the UK.

What clinics look for: For Sativex: you need a diagnosis of MS and evidence that at least two antispasticity medications have been inadequate. Sativex is prescribed by neurologists. NHS funding is available but requires demonstrating a meaningful initial response.

From MedCannaIndex. Fees and product details are as recorded there and should be confirmed with the clinic or pharmacy. This is not medical advice: which product is suitable, and how much, is for the prescribing specialist.